Skip to main content
. 2011 Jan 17;13(4):255–260. doi: 10.1093/ntr/ntq248

Table 3.

Cessation Medication Use at 12-Week Follow-Up, Respondents Only

N NRT (%) Varenicline (%) Bupropion (%) Any Medication (%)
Group
    IVR 222 32 18 3 47
    IVR + CB 224 35 19 3 52
CB offera
    Refused offer 96 34 18 2 52
    Accepted offer 58 52 24 3 69

Note. aIncludes only those offered a call back.